Roberts Jonathan C
Known title: EVP & Chief Operating OfficerCIK: 0001410515
Associated companies
Transaction History
| CVS | ▲ Buy | Grant | 322,395 | $0 | 2/21/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 68,482 | $7.0M | 1/27/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 68,482 | $7.4M | 1/27/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 108,870 | $5.0M | 11/3/2021 | View on chart |
| CVS | ▼ Sell | Open Market | 108,870 | $10.3M | 11/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.